MENU
+Compare
MEDX
ETF ticker: NASDAQ
AS OF
Jul 17 closing price
Price
$27.47
Change
-$0.38 (-1.36%)
Net Assets
15.81M

MEDX stock forecast, quote, news & analysis

The investment seeks to provide long-term growth of capital... Show more

Category: #Health
MEDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for MEDX with price predictions
Jul 17, 2025

Aroon Indicator for MEDX shows an upward move is likely

MEDX's Aroon Indicator triggered a bullish signal on July 15, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 94 similar instances where the Aroon Indicator showed a similar pattern. In of the 94 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 02, 2025. You may want to consider a long position or call options on MEDX as a result. In of 35 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MEDX just turned positive on July 02, 2025. Looking at past instances where MEDX's MACD turned positive, the stock continued to rise in of 20 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MEDX advanced for three days, in of 163 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MEDX moved out of overbought territory on July 15, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 12 similar instances where the indicator moved out of overbought territory. In of the 12 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 30 cases where MEDX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

MEDX broke above its upper Bollinger Band on July 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Bristol-Myers Squibb Co (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB).

Industry description

The investment seeks to provide long-term growth of capital. The fund is an actively-managed exchange-traded fund (“ETF”) that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries. The fund is non-diversified.

Market Cap

The average market capitalization across the Horizon Kinetics Medical ETF ETF is 89.36B. The market cap for tickers in the group ranges from 1.3M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is SLRX at 1.3M.

High and low price notable news

The average weekly price growth across all stocks in the Horizon Kinetics Medical ETF ETF was -2%. For the same ETF, the average monthly price growth was 3%, and the average quarterly price growth was 7%. LTRN experienced the highest price growth at 22%, while SLRX experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Horizon Kinetics Medical ETF ETF was 18%. For the same stocks of the ETF, the average monthly volume growth was -22% and the average quarterly volume growth was 16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 77
Price Growth Rating: 51
SMR Rating: 71
Profit Risk Rating: 80
Seasonality Score: 5 (-100 ... +100)
View a ticker or compare two or three
MEDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Listed Funds Trust490 Royal Lake DriveCape Girardeau
Phone
N/A
Web
N/A